JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

JNJ

186.16

-1.49%↓

ABT

123.72

+0.11%↑

TMO

565.18

-0.5%↓

ISRG

544.08

+1.81%↑

DHR

214.08

-0.71%↓

Home・Akcijų sąrašas・Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

30.48 -3.36

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

29.67

Max

31.54

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+55.16% upside

Dividendai
By Dow Jones
Kitas uždarbis	2025-11-04

Naujienos nuotaikos

By Acuity

50%

156 / 373 reitingas Healthcare

Rigel Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-03 21:44; UTC

Uždarbis

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

2025-11-03 23:44; UTC

Rinkos pokalbiai

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

2025-11-03 23:34; UTC

Rinkos pokalbiai

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

2025-11-03 23:28; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

2025-11-03 23:24; UTC

Uždarbis

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025-11-03 23:14; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Global Equities Roundup: Market Talk

2025-11-03 23:14; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

2025-11-03 23:12; UTC

Uždarbis

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

2025-11-03 23:09; UTC

Uždarbis

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

2025-11-03 23:06; UTC

Rinkos pokalbiai

Uždarbis

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

2025-11-03 22:36; UTC

Rinkos pokalbiai

Uždarbis

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

2025-11-03 22:31; UTC

Uždarbis

Franco-Nevada 3Q EPS $1.49 >FNV

2025-11-03 22:31; UTC

Uždarbis

Franco-Nevada 3Q Rev $487.7M >FNV

2025-11-03 22:24; UTC

Rinkos pokalbiai

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

2025-11-03 22:19; UTC

Įsigijimai, susijungimai, perėmimai

Starbucks Agrees to Sell Stake in China Business -- WSJ

2025-11-03 21:59; UTC

Rinkos pokalbiai

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

2025-11-03 21:54; UTC

Rinkos pokalbiai

Uždarbis

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

2025-11-03 21:54; UTC

Rinkos pokalbiai

Uždarbis

Global Equities Roundup: Market Talk

2025-11-03 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-03 21:49; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

2025-11-03 21:40; UTC

Uždarbis

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

2025-11-03 21:31; UTC

Rinkos pokalbiai

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

2025-11-03 21:19; UTC

Uždarbis

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

2025-11-03 21:11; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

2025-11-03 21:11; UTC

Uždarbis

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

2025-11-03 21:07; UTC

Uždarbis

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

2025-11-03 21:05; UTC

Uždarbis

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

2025-11-03 21:05; UTC

Uždarbis

Palantir Technologies 3Q Net $475.6M >PLTR

Akcijų palyginimas

Kainos pokytis

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

55.16% į viršų

12 mėnesių prognozė

Vidutinis 49 USD 55.16%

Aukščiausias 67 USD

Žemiausias 23 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Rigel Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Rigel Pharmaceuticals Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Rinkos nuotaikos

By Acuity

156 / 373 reitingas Sveikatos priežiūra

Finansinės naujienos

Kitos sektoriaus akcijos

JNJ

Johnson and Johnson

186.16

↓-1.49%

ABT

Abbott Laboratories

123.72

↑ +0.11%

TMO

Thermo Fisher Scientific Inc

565.18

↓-0.5%

ISRG

Intuitive Surgical Inc

544.08

↑ +1.81%

DHR

Danaher Corp

214.08

↓-0.71%

Rigel Pharmaceuticals Inc

Apžvalga

Akcijų kainos pasikeitimas

Rekomendacijos

Dividendai

Naujienos nuotaikos

Rigel Pharmaceuticals Inc Grafikas

Susijusios naujienos

Akcijų palyginimas

Rigel Pharmaceuticals Inc Prognozė

Kainos tikslas

Bendras įvertinimas

Rinkos nuotaikos

Finansinės naujienos

Kitos sektoriaus akcijos